Eton Pharmaceuticals, Inc. (ETON)

Eton Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	37.12	14.94	21.39	16.31	14.41	21.3
Cash & Short-Term Investments	37.12	14.94	21.39	16.31	14.41	21.3
Cash Growth	83.21%	-30.17%	31.17%	13.18%	-32.35%	76.49%
Receivables	13.08	5.36	3.41	1.85	5.47	0.05
Inventory	16.86	15.23	0.91	0.56	0.55	1.24
Prepaid Expenses	4.94	5.49	1.13	1.29	3.18	2.12
Total Current Assets	72	41.02	26.84	20	23.6	24.7
Property, Plant & Equipment	0.61	0.21	0.15	0.26	0.22	1
Other Intangible Assets	31.88	34.88	4.74	4.75	3.62	0.58
Other Long-Term Assets	0.02	0.01	0.01	0.01	0.02	0.04
Total Assets	104.51	76.12	31.74	25.03	27.47	26.32
Accounts Payable	14.26	4.17	1.85	1.77	1.77	2.34
Accrued Expenses	24.16	15.7	8.96	3.66	1.37	1.17
Current Portion of Long-Term Debt	2.78	-	5.38	1.03	1.42	0.28
Current Portion of Leases	0.03	0.08	0.05	-	-	-
Total Current Liabilities	44.18	19.95	16.24	6.46	4.56	3.79
Long-Term Debt	27.59	29.81	-	5.38	5.26	6.76
Long-Term Leases	0.48	0.11	0.02	0.11	0.02	0.1
Other Long-Term Liabilities	7.37	1.83	-	-	-	-
Total Liabilities	81.38	51.7	16.26	11.95	9.84	10.66
Common Stock	0.03	0.03	0.03	0.03	0.03	0.02
Additional Paid-In Capital	137.08	132.29	119.52	116.19	111.72	107.8
Retained Earnings	-113.98	-107.89	-104.07	-103.13	-94.11	-92.16
Total Common Equity	23.13	24.43	15.48	13.08	17.63	15.66
Shareholders' Equity	23.13	24.43	15.48	13.08	17.63	15.66
Total Liabilities & Equity	104.51	76.12	31.74	25.03	27.47	26.32
Total Debt	30.88	29.99	5.46	6.52	6.7	7.14
Net Cash (Debt)	6.24	-15.06	15.93	9.78	7.71	14.15
Net Cash Growth	-60.82%	-	62.90%	26.85%	-45.52%	88.53%
Net Cash Per Share	0.23	-0.58	0.62	0.39	0.31	0.67
Filing Date Shares Outstanding	26.82	26.82	25.69	25.46	24.63	24.41
Total Common Shares Outstanding	26.82	26.71	25.69	25.35	24.63	24.31
Working Capital	27.82	21.07	10.6	13.54	19.05	20.91
Book Value Per Share	0.86	0.91	0.60	0.52	0.72	0.64
Tangible Book Value	-8.75	-10.45	10.74	8.32	14.01	15.09
Tangible Book Value Per Share	-0.33	-0.39	0.42	0.33	0.57	0.62
Machinery	-	0.38	0.35	0.34	0.4	1.32
Construction In Progress	-	-	-	0.01	-	-
Leasehold Improvements	-	0.1	0.1	0.07	0.07	0.18

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q